Compassionate and optimum use of new tuberculosis drugs

The Lancet Infectious Diseases

Volumn 15, Issue 10, 2015, Pages 1131-

  Reed, Caitlin ^a,b   Mason, Leona ^a   Cox, Helen ^c   Seaworth, Barbara ^d   Lessem, Erica ^e   Furin, Jennifer ^f  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d Heartland National TB Center   (United States)

^e TB HIV Project Treatment Action Group   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; BEDAQUILINE; CAPREOMYCIN; CLOFAZIMINE; CYCLOSERINE; DELAMANID; DORIPENEM; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID PLUS PYRAZINAMIDE PLUS RIFAMPICIN; KANAMYCIN; LINEZOLID; MOXIFLOXACIN; OFLOXACIN; TUBERCULOSTATIC AGENT; NITROIMIDAZOLE DERIVATIVE; OPC-67683; OXAZOLE DERIVATIVE; QUINOLINE DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CASE REPORT; COMPASSIONATE USE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESISTANT TUBERCULOSIS; DRUG USE; HUMAN; LETTER; LUNG RESECTION; MALE; MYCOBACTERIUM TUBERCULOSIS; NEUROPATHY; NONHUMAN; OPTIMAL DRUG DOSE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SPUTUM SMEAR; THORAX RADIOGRAPHY; DRUG COMBINATION; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HEALTH CARE DELIVERY; PROCEDURES;

ADULT; ANTITUBERCULAR AGENTS; DIARYLQUINOLINES; DRUG THERAPY, COMBINATION; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; NITROIMIDAZOLES; OXAZOLES; PNEUMONECTOMY;

EID: 84942091323     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)00294-7     Document Type: Letter

References (3)

1. Zumla A, Gillespie S, Hoelscher M, et al. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. Lancet Infect Dis 2014, 14:327-340.
2. Tuberculosis control laws and policy: a handbook for legal and public health practitioners Centers for Disease Control and Prevention, (accessed April 28, 2014). http://www.cdc.gov/tb/programs/TBLawPolicyHandbook.pdf.
3. Shah NS, Brust JC, Mathema B, et al. Majority of XDR TB cases are due to transmission in a high-HIV-prevalence setting. 2015 Conference on retroviruses and opportunistic infections; Seattle, WA; Feb 23-24, 2015. Abstract 92.